Amneal Focuses On Complex Generics As Revenues See Double-Digit Growth

Company Also Plans To File 30 ANDAs This Year

Rocket
Amneal’s generics business sees double-digit growth, as the company prepares for more complex generic product launches • Source: Shutterstock

More from Strategy

More from Business